Trusted Resource for Clinical Trials, Protocols & Progress
Regulatory authorities view training compliance as a cornerstone of Good Clinical Practice (GCP). When site staff fail to complete timely training renewals—whether for protocol amendments, SOP changes, or annual GCP refreshers—it triggers risks for data integrity, patient safety, and inspection outcomes.
Click to read the full article.
Clinical trials often span several years—especially in oncology, neurology, and rare disease indications. During such extended timelines, site staff turnover, protocol amendments, and SOP changes make it essential to maintain ongoing training. Regulatory authorities like the FDA, EMA, and PMDA increasingly expect sponsors and CROs to demonstrate structured oversight of training throughout the study lifecycle—not just during trial initiation.
Click to read the full article.
In clinical trials, training currency refers to the timeliness, relevance, and documentation of training received by site personnel. It is a focal point in audits and inspections conducted by regulatory authorities like the FDA, EMA, and PMDA. Sites must demonstrate that all staff have received role-appropriate, up-to-date training prior to and throughout the course of their delegated trial activities.
Click to read the full article.
Staff turnover is a reality in clinical research, especially at large hospitals, academic medical centers, and CRO-managed site networks. Frequent personnel changes—especially among nurses, pharmacists, and research coordinators—can lead to lapses in trial education, GCP compliance, and delegation documentation. Regulatory inspectors routinely cite training gaps as a critical deficiency at high-turnover sites.
Click to read the full article.
